Enjoy complimentary customisation on priority with our Enterprise License!
The rapid diagnostics market size is forecast to increase by USD 11.76 billion at a CAGR of 7.08% between 2023 and 2028. The market is experiencing significant growth due to the increasing incidence of chronic and infectious diseases, such as cancer, cardiac conditions, and infectious diseases, which necessitate routine testing. The market is driven by the growing presence of Original Equipment Manufacturers offering advanced diagnostic solutions for proteins, health conditions, and disease detection. However, the high cost of rapid diagnostic products remains a major challenge, limiting accessibility in underserved populations and markets. Key application areas include blood glucose testing, cardiac markers, lipid profile, and cholesterol testing. The market is expected to continue its growth trajectory, driven by technological advancements and increasing demand for accurate, quick, and cost-effective diagnostic solutions.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.